RELX (LSE: REL) gains 1.2% as relief bounce builds after AI-driven 12.7% ten-day slide

RELX (LSE: REL) shares rose 1.23% to 2,394p on Friday, May 15, 2026, extending a fragile recovery from the 4.97% slump on May 13 that took the stock to a two-and-a-half year low. The information and analytics group, owner of LexisNexis, Elsevier, ICIS and the Reed Exhibitions business, has been one of the worst FTSE 100 performers in 2026, down 17.5% year-to-date as investors grapple with whether generative AI will erode the high-margin subscription businesses that have driven a decade of compound earnings growth. The Friday bounce reflects continued analyst support for the long-term investment thesis, with both Deutsche Bank and UBS reiterating Buy ratings despite cutting price targets to reflect higher discount rates and sector de-rating. The next major catalyst is the H1 2026 results in late July, which will give investors the first hard read on whether AI competition is showing in actual subscription renewal rates.

What does RELX actually do, and why are its four divisions facing different AI exposures?

RELX is a global provider of information-based analytics and decision tools for professional and business customers, organised into four segments. Risk, the largest and fastest-growing division, provides financial crime compliance, fraud prevention, identity verification and insurance underwriting analytics, combining public and industry-specific content with proprietary algorithms. Scientific, Technical & Medical, anchored by the Elsevier brand, publishes academic journals, builds research workflow tools and provides clinical decision support to healthcare professionals. Legal, the LexisNexis business, offers legal research, regulatory and business information, with the Lexis+ AI platform and the newer Protégé product representing the group’s most direct AI-enabled subscription offering. Exhibitions runs the Reed face-to-face events business, supplemented increasingly with data and digital tools.

For 2025, RELX reported revenue of £9.59 billion, up 2% reported and 7% on an underlying organic basis. Adjusted operating profit rose 9% organic to £3.34 billion, with margins expanding 90 basis points to 34.8%. Free cash flow was £2.31 billion, supporting a 99% cash conversion ratio, a 7% dividend increase to 67.5p, and a £1.5 billion buyback completed during the year. The company employs around 36,000 people across more than 40 countries, with approximately half of its 12,000 LexisNexis staff dedicated to data cleaning, management and AI training rather than traditional editorial work.

The risk environment varies significantly across the four divisions. Risk has the strongest AI moat because financial crime compliance datasets require regulated, audit-trail-quality records that no general-purpose AI model can substitute. STM faces moderate disruption risk in the search and discovery layer, but the underlying journals retain protection through copyright and peer review. Legal is the most exposed division, with the February 2026 Anthropic agentic AI plug-in launch including a legal review tool that directly competes with LexisNexis offerings. Exhibitions remains the least AI-exposed business but has limited growth potential. The market is currently pricing the legal threat as a group-wide risk, which most analysts argue overstates the actual exposure.

Why did the February 2026 Anthropic agentic AI launch trigger the deepest RELX share price selloff in recent memory?

The single most consequential event for RELX shares in 2026 was the early February launch by Anthropic of an 11-product agentic AI plug-in suite, which included a tool aimed at in-house legal teams and academic researchers capable of reviewing documents, flagging compliance risks and tracking regulatory changes. The market reaction was severe. RELX shares fell as much as 15% in a single session on the launch news, and the stock subsequently slid more than 40% over six months as investors questioned whether subscription pricing power across the legal information industry could be sustained.

The substantive question is whether the Anthropic tool genuinely substitutes for LexisNexis, or whether it complements existing workflows without displacing the underlying data subscription. Early user feedback reported by MoneyWeek and other outlets cited sloppy or fabricated results when the Anthropic tool was relying on freely available data sources such as Wikipedia rather than the proprietary case law databases that LexisNexis spends approximately $2 billion per year cleaning and indexing. LexisNexis hosts over 161 billion legal and news documents and adds 1.6 million new documents per day, processing 38 million legal documents per day across the platform.

The risk for investors is that the market has not yet completed its repricing. Even if the proprietary data moat is real, the broader concern is that AI-enabled productivity tools reduce the number of billable hours, the size of legal teams, and the total addressable market for legal information services. If the long-term price elasticity of demand for LexisNexis subscriptions is more negative than RELX management has signalled, the structural growth rate could compress from the recent 8% to 9% range to mid-single-digits over the next five years. That alone would justify a meaningful valuation de-rating versus the historic five-year average price-to-earnings multiple of around 24 times.

How does the April 23 AGM trading update and £2.25 billion buyback fit into the broader recovery thesis?

The April 23, 2026 AGM trading update reaffirmed full-year guidance and pointed to positive momentum across all four divisions, with chief executive Erik Engstrom describing growth as increasingly driven by a shift toward higher-value products, particularly AI-enabled analytics tools. The Risk division highlighted demand for financial crime compliance and fraud solutions, while Legal delivered strong growth helped by the uptake of Lexis+ with Protégé. STM showed improving momentum, and Exhibitions continued to recover post-pandemic.

The buyback structure is unusually large for RELX. The new programme announced on April 23, 2026 authorises buyback of up to 182,800,000 shares, or 10.07% of issued share capital. This sits on top of the £2.25 billion programme announced in February 2026 alongside the full-year results, which was already larger than the £1.3 billion consensus expectation. Between July 1, 2025 and February 11, 2026, RELX repurchased 15.9 million shares for £750 million, completing a total buyback of 29.77 million shares, or 1.63% of share capital, for £1.3 billion under the April 2025 programme.

The execution risk is timing rather than capacity. RELX has £2.31 billion of annual free cash flow, leverage of just 2.0 times net debt to EBITDA, and 99% cash conversion. The capacity for substantial buyback execution is unquestioned. The question is whether buyback at recent prices around 2,300p to 2,500p represents an effective use of capital. If the AI disruption narrative is overdone and the shares re-rate back to 3,000p over 12 months, the buyback will look like excellent capital deployment. If the disruption is real and shares slide further, the buyback effectively transfers value from shareholders to selling shareholders ahead of the trend.

How is the analyst community currently positioned, and what does the price target dispersion tell investors?

The analyst community has cut price targets meaningfully but remains broadly constructive. Deutsche Bank cut its target to 3,050p from 3,700p but retained a Buy rating. UBS moved to 3,600p from 4,570p, also maintaining Buy. The dispersion is unusually wide for a FTSE 100 stock. Simply Wall St’s fair value estimate sits at £36.18, down from £36.42, against a current share price of 2,394p, implying around 51% upside. BofA’s price target, expressed in the New York-listed ADR, is $47.20, up from $46.

The bull case is anchored on three points. First, RELX trades on a forecast 2026 price-to-earnings multiple of around 14.8 times, well below the five-year average of 24.1 times. Second, the £2.25 billion buyback programme, combined with steady high single-digit dividend growth and a 99% cash conversion ratio, provides strong shareholder returns even if revenue growth moderates. Third, the proprietary data moat in Risk and the regulated nature of legal compliance work limit the substitutability of AI tools for the underlying RELX information assets.

JPMorgan has explicitly argued that AI should reinforce RELX’s competitive position rather than undermine it, noting that the ability to embed AI into mission-critical workflows means the technology deepens customer relationships rather than displacing them. The bank’s duration sensitivity analysis points out that if RELX’s strong cashflow growth were assumed to persist for longer, extending the forecast period from 2035 to 2040, the implied valuation could reach approximately 5,820p under an 8% annual cashflow growth assumption. That is a theoretical maximum rather than a target, but it illustrates the asymmetric upside if the AI threat proves overblown.

What does the Risk division alone justify within RELX’s current valuation?

Risk is the most under-appreciated part of the RELX investment case. The division provides financial crime compliance, fraud prevention, identity verification, anti-money laundering screening and insurance underwriting analytics to banks, insurers, government agencies and other regulated industries. These services are mission-critical, with customers facing direct regulatory penalties for non-compliance. The data feeds and analytics are deeply embedded in customer workflows, with switching costs measured in months and the risk of compliance failures during transition limiting customer churn.

Risk generated approximately 35% of group revenue and a higher proportion of group profit in 2025, with double-digit organic growth in core sub-segments. The competitive position is genuinely defensible because the proprietary identity verification datasets, sanctions screening lists and adverse media monitoring feeds cannot be replicated through general-purpose AI tools. Customers cannot simply substitute the LexisNexis Risk feed with a ChatGPT or Claude query without breaching their compliance obligations.

If Risk were valued as a standalone business at the multiples accorded to comparable US-listed data analytics peers such as Verisk Analytics, S&P Global or Moody’s, the implied valuation alone could approach the bulk of RELX’s current market capitalisation. UBS and Deutsche Bank sum-of-the-parts analyses have repeatedly highlighted that the rest of RELX, including the AI-threatened Legal business, is effectively being acquired at minimal cost when the market values the consolidated group at current levels.

What are the execution risks Erik Engstrom and the RELX team face over the next 12 months?

Erik Engstrom, chief executive since 2009, has overseen one of the most consistent compound growth stories in the FTSE 100 over the past 15 years. His tenure has been characterised by disciplined acquisitions, sustained product investment, and a clear strategic pivot away from print publishing toward digital analytics. The risk is that the company is now facing its first genuine technological disruption since the journal-to-digital transition of the 2000s, and the playbook that delivered the last decade of growth may not be sufficient for the AI era.

The first specific risk is Lexis+ AI and Protégé adoption. If renewal rates for these AI-enabled Legal products show any signs of weakness in the H1 2026 results in late July, the share price will face another leg down. Management has been emphatic that there are no signs of AI-driven disruption in actual subscription metrics, but the market is currently pricing the opposite scenario.

The second risk is the pace of product innovation. RELX spends approximately $2 billion per year on technology and data investment, but the question is whether that spending is sufficient to keep pace with the rapid advance of generative AI capabilities at companies like Anthropic, OpenAI and Google. If new AI products are launched faster than RELX can embed equivalent functionality into LexisNexis, Elsevier and the Risk platforms, the competitive gap could widen.

The third risk is foreign exchange and macroeconomic. Approximately 60% of RELX revenue is generated in US dollars, meaning sterling strength translates to lower reported revenue and earnings. Sterling has appreciated modestly against the US dollar through early 2026, creating a 3% to 4% currency headwind that partially offsets the 8% to 9% underlying organic growth in the core divisions.

Why are retail investors on UK forums increasingly viewing RELX as a contrarian recovery play?

Forum chatter on London South East, ADVFN and Stockopedia has shifted noticeably over the past few weeks. The dominant theme through Q1 2026 was AI disruption fear, with frequent comparisons to Kodak, Blockbuster and other businesses disrupted by technological change. The narrative is now bifurcating. Bears continue to argue that the structural threat is real and that the share price has further to fall as renewal cycle data emerges through H1 and H2 2026. Bulls are increasingly framing RELX as one of the most asymmetric risk-reward opportunities in the FTSE 100, citing the gap between the current 14.8 times forecast earnings multiple and the historic 24 times average.

The Motley Fool UK and MoneyWeek have run multiple recent articles framing RELX as potentially the most misunderstood stock in the index. The bull case rests on the proprietary data moat being genuinely defensible, the management team having a 15-year track record of consistent execution, the buyback programme providing shareholder return support, and the dividend yield of around 2.8% at the current share price providing income to investors willing to hold through the recovery cycle.

The retail investor risk is that recovery cycles can be lengthy. Even if the AI disruption thesis proves overdone, the share price re-rating back to even 20 times forecast earnings would require sustained evidence over multiple quarters that subscription metrics are not deteriorating. The first credible inflection point is the H1 2026 results in late July, with each subsequent quarterly print providing additional data points. The earliest realistic timeline for a full recovery back to the 2025 highs of around 3,800p is therefore 2027 or 2028.

Key catalysts and watchpoints for RELX shareholders over the coming months

• RELX shares rose 1.23% to 2,394p on May 15, 2026, building on a tentative recovery from the May 13 slump that took the stock to a two-and-a-half year low of 2,333p amid persistent investor concern about AI disruption to its core LexisNexis and Elsevier brands.
• The February 2026 launch by Anthropic of an 11-product agentic AI plug-in suite, including a legal review tool, triggered a 15% single-day fall and a broader 40% six-month decline as investors questioned whether subscription pricing power in legal information services would survive AI competition.
• The £2.25 billion share buyback announced February 2026, supplemented by the April 23 authorisation to repurchase up to 10.07% of share capital, represents the largest capital return commitment in RELX history and signals board confidence in long-term cash generation.
• Deutsche Bank and UBS have cut price targets to 3,050p and 3,600p respectively while retaining Buy ratings, with sum-of-the-parts analyses pointing to the Risk division alone justifying a substantial proportion of the current market capitalisation.
• RELX trades on a forecast 2026 price-to-earnings multiple of approximately 14.8 times, materially below the five-year average of 24.1 times, with a 51% upside implied by the Simply Wall St fair value estimate of £36.18.
• The H1 2026 results in late July will be the first major test of whether subscription renewal rates are showing any AI-driven weakness, with Lexis+ AI and Protégé adoption metrics being closely watched by analysts and investors.
• LexisNexis hosts more than 161 billion legal and news documents, adds 1.6 million new documents per day, and spends approximately $2 billion per year on technology and data investment, with around half of its 12,000 staff dedicated to data cleaning and AI training.
• The Risk division, providing financial crime compliance, fraud prevention and identity verification, remains the most defensible part of the RELX investment case, with regulatory mandates and customer switching costs limiting AI substitution risk.